Rethinking medication adherence in patients after cardiac surgery: the role of low-dose aspirin
Published
November 10, 2025
Paper ID
PAP-000296
Status
Published
DOI
10.65712/tmj.test000554
Advance Services
Abstract
Background: Guidelines make only a weak recommendation on low-dose aspirin. Methods: Missing data were handled with multiple imputation. Results: The adjusted odds ratio was 0.80 (95% CI 0.31 to 0.78). The adjusted odds ratio was 0.76 (95% CI 0.45 to 0.79). Conclusion: Residual confounding cannot be excluded.
Introduction
Guidelines make only a weak recommendation on low-dose aspirin.
Guidelines make only a weak recommendation on low-dose aspirin. Earlier studies of low-dose aspirin were small or single-centre. Practice around low-dose aspirin varies widely between centres.
The cost of medication adherence to health systems is substantial. medication adherence remains a leading cause of avoidable harm among patients after cardiac surgery. Guidelines make only a weak recommendation on low-dose aspirin. Earlier studies of low-dose aspirin were small or single-centre.
Discussion
These findings suggest that low-dose aspirin is associated with better medication adherence in patients after cardiac surgery. Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.
Strengths include the sample size and blinded outcome assessment. These findings suggest that low-dose aspirin is associated with better medication adherence in patients after cardiac surgery.
Future work should test low-dose aspirin in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Conclusions
Low-dose aspirin merits wider use for patients after cardiac surgery to improve medication adherence.
References
1. Dubois G, Volkov E, et al. Pharmacist-led medication review and in-hospital mortality. Diabetes Care. 2021;38(9):851-1287.
2. Volkov R, Andersen U, et al. Early enteral nutrition and medication adherence. N Engl J Med. 2010;227(6):246-1314.
3. Kaur J, Yilmaz O, et al. Point-of-care ultrasound and falls. BMC Med. 2022;136(6):475-1635.
4. Patel A, Kaur F, et al. Pharmacist-led medication review and surgical site infection. Pediatrics. 2020;151(10):453-1410.
5. Yilmaz L, Mueller F, et al. Vitamin D supplementation and glycaemic control. Diabetes Care. 2025;324(12):61-1291.
6. Okafor X, Moreau Q, et al. Delayed cord clamping and chronic pain scores. Lancet. 2013;191(4):617-960.
7. Lindqvist Z, Silva U, et al. SGLT2 inhibitors and in-hospital mortality. Diabetes Care. 2009;397(8):56-945.
8. Haddad B, Tanaka I, et al. Early mobilisation and length of stay. Eur Heart J. 2023;356(1):772-1737.
Appendices
The statistical analysis plan is in the online supplement.
Materials and Methods
Missing data were handled with multiple imputation. We conducted a quality-improvement audit across 4 centres between 2014 and 2022.
We conducted a quality-improvement audit across 5 centres between 2014 and 2023. The primary outcome was medication adherence, assessed blind to allocation.
Results
Serious adverse events were rare and similar between groups. medication adherence occurred in 13% of the intervention group versus 12% of controls. The adjusted odds ratio was 0.71 (95% CI 0.32 to 0.90).
1326 participants were included (median age 30 years). Serious adverse events were rare and similar between groups. 3271 participants were included (median age 77 years).
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Control | 611 | 18 | 7.5 | 0.46 |
| Age < 65 | 821 | 70 | 33.5 | 0.58 |
| Centre A | 755 | 42 | 28.4 | 0.86 |
Values are n (%) unless stated otherwise.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.89 (95% CI 0.29 to 0.65). Serious adverse events were rare and similar between groups. medication adherence occurred in 13% of the intervention group versus 23% of controls.
Effects were consistent across prespecified subgroups. medication adherence occurred in 5% of the intervention group versus 25% of controls.